IMMUNE PHARMACEUTICALS INC 4
4 · IMMUNE PHARMACEUTICALS INC · Filed Dec 3, 2014
Insider Transaction Report
Form 4
Stancic Ana
Director
Transactions
- Purchase
Warrant
2014-11-26+2,000→ 2,000 totalExercise: $3.75From: 2014-11-26Exp: 2017-11-26→ Common Stock (2,000 underlying) - Purchase
Common Stock
2014-11-26$2.50/sh+8,000$20,000→ 8,000 total
Footnotes (1)
- [F1]The securities were purchased by the Reporting Person in connection with the underwriter's partial exercise of its over-allotment option to purchase additional units in the Issuer's underwritten public offering that closed on November 25, 2014.